ClinicalTrials.gov
public full text
Public Domain
Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient
The aim of this study is the comparison between the effects of supplementation with vitamin A (retinyl palmitate) or placebo for 6 months on gene expression of T CD4+ lymphocyte in multiple sclerotic patient.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Multiple sclerosis-associated CD226 variant disrupts vitamin D-induced type I Treg differentiation by impairing LFA-1 activation#983956
- Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis#891552
- Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis#948034
- Impact of cancer on multiple sclerosis–related healthcare and disease-modifying drug use: A multinational cohort study#337511
- The art of sequencing disease-modifying therapies in multiple sclerosis#661843
Record · ID 830824
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive